Search research articles
Contact Us
Filters
Showing results (61-70 of 102) with videos related to
Page
of 11
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 15, 1998
Activation-induced resetting of cerebral oxygen and glucose uptake in the rat
P L Madsen, R Linde, S G Hasselbalch, et al.
International Journal of Fertility
|
January 1, 1982
Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men
G Doelle, R Linde, N Alexander, et al.
Biological Trace Element Research
|
May 25, 2020
Cytosolic and Metallothionein-Bound Hepatic Metals and Detoxification in a Sentinel Teleost, Dules auriga, from Southern Rio de Janeiro, Brazil
R A Hauser-Davis, D R Silva-Junior, A R Linde-Arias, et al.
Izvestiia Akademii Nauk SSSR. Seriia Biologicheskaia
|
November 1, 1970
[Modified method of synthesizing 1,4-dithiotreitol (Cleland reagent)]
G I Slepko, V R Linde, A M Uzenskaia, et al.
AIDS (London, England)
|
August 10, 2000
Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing
T Schuster, R Linde, U Wintergerst, et al.
AIDS (London, England)
|
June 16, 2001
Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy
R Linde, M B Funk, T Schuster, et al.
Vox Sanguinis
|
May 9, 2015
An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency disease
G Kriván, Ch Königs, E Bernatowska, et al.
The New England Journal of Medicine
|
September 17, 1981
Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive
R Linde, G C Doelle, N Alexander, et al.
European Journal of Medical Research
|
November 15, 2006
Need for therapeutic drug monitoring in HIV-1 infected children receiving efavirenz doses according to international guidelines
Nils von Hentig, C Koenigs, S Elanjikal, et al.
Journal of Clinical Immunology
|
May 23, 2000
Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children
B Gröschel, J J Braner, M Funk, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 102) with videos related to
Sort By:
Page
of 11
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 15, 1998
Activation-induced resetting of cerebral oxygen and glucose uptake in the rat
P L Madsen, R Linde, S G Hasselbalch, et al.
International Journal of Fertility
|
January 1, 1982
Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men
G Doelle, R Linde, N Alexander, et al.
Biological Trace Element Research
|
May 25, 2020
Cytosolic and Metallothionein-Bound Hepatic Metals and Detoxification in a Sentinel Teleost, Dules auriga, from Southern Rio de Janeiro, Brazil
R A Hauser-Davis, D R Silva-Junior, A R Linde-Arias, et al.
Izvestiia Akademii Nauk SSSR. Seriia Biologicheskaia
|
November 1, 1970
[Modified method of synthesizing 1,4-dithiotreitol (Cleland reagent)]
G I Slepko, V R Linde, A M Uzenskaia, et al.
AIDS (London, England)
|
August 10, 2000
Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing
T Schuster, R Linde, U Wintergerst, et al.
AIDS (London, England)
|
June 16, 2001
Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy
R Linde, M B Funk, T Schuster, et al.
Vox Sanguinis
|
May 9, 2015
An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency disease
G Kriván, Ch Königs, E Bernatowska, et al.
The New England Journal of Medicine
|
September 17, 1981
Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive
R Linde, G C Doelle, N Alexander, et al.
European Journal of Medical Research
|
November 15, 2006
Need for therapeutic drug monitoring in HIV-1 infected children receiving efavirenz doses according to international guidelines
Nils von Hentig, C Koenigs, S Elanjikal, et al.
Journal of Clinical Immunology
|
May 23, 2000
Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children
B Gröschel, J J Braner, M Funk, et al.
Page
of 11